The Madrid campus of Clinica unviersidad de Navarra has hosted the kick-off meeting of the international project “Early detection and intervention: Understanding the mechanisms of transformation and hidden resistance of incurable haematological malignancies”, a collaboration of 13 Research Institutions from the UK, Spain and Italy funded through a partnership between Cancer Research UK, Fondazione AIRC and Fundación Científica de [...]

Detectar los tumores hematológicos de forma precoz para tratarlos lo más tempranamente posible y, así, poder lograr su curación es el objetivo principal de una investigación internacional que ha sido seleccionada con carácter prioritario  por un consorcio europeo de asociaciones contra el cáncer. El proyecto ha recibido una de las 6 ayudas “Accelerator Awards”, una convocatoria internacional cuyo objetivo [...]

BCI researchers are lead members of an international team to be funded by an Accelerator Award, which will bring together scientists from the UK, Spain and Italy in a bid to improve early detection and intervention of blood cancers. The award of £4.8M over 5 years, funded through a partnership between Cancer Research UK (CRUK), AIRC and FC AECC, encourages cross-institutional collaboration to unite resources [...]

A new international Accelerator Award is funding researchers from the UK, Spain and Italy to improve early detection and intervention of haematological malignancies. The team is working together to develop disease models and produce data for studying blood cancers at an earlier stage. We talked to the lead investigator, Professor Jesus San Miguel – the Director of Clinical and [...]

March 2020. The Steering Board from the EDITOR project, an international early detection and intervention of blood cancer research, held its third scientific meeting by videoconference.  Clinica Universidad de Navarra (Spain) organised this meeting in which 36 researchers attended. They represented the 13 research institutions from the United Kingdom, Italy and Spain that are part of the project. Also, [...]

December 2019. EDITOR project, focused on improving early detection and intervention of blood cancers, has completed a year with a positive balance in its forecasts. It started in its kick-off meeting held in January 2019 at Clinica Universidad de Navarra headquarters in Madrid (Spain). During this year the 13 institutions -from Spain, Italy and the United Kingdom- that form [...]

(WASHINGTON, April 29, 2020) — In a special report published today in the journal Blood, an international working group of experts in myelodysplastic syndromes (MDS) proposes – for the first time – the recognition of a distinct subtype of MDS based on the presence of a nonheritable genetic mutation that causes the disease. The mutation is found in approximately [...]

(Pamplona, Spain, August 20, 2020) — A joint research by groups of the EDITOR Accelerator Award have discovered a molecular trait that is shared by myeloma patients. Multiple myeloma is a greatly heterogeneous disease, both from biological and clinical perspectives. In spite of this heterogeneity, several groups of the EDITOR accelerator award have discovered a molecular trait that is [...]

The 2020 has been a year marked by the pandemic. The global health crisis has slowed down, or even paralysed, the scientific activity of biomedical research centres, especially in Europe. In this context, the laboratories involved in the Editor project have continued to work on the knowledge of haematological diseases at the rate that the pandemic has allowed, resuming [...]

Researchers at the Clinica Universidad de Navarra and CIMA Universidad de Navarra are leading an international study which has revealed a novel set of genes specific to multiple myeloma which condition its manifestation and development The research also shows that the expression of these genes allows for better classification of patients with this disease in terms of survival The [...]

The EDITOR project, a collaboration of 13 research institutions from the UK, Spain and Italy, is entering it´s final year. Thorugh out the four years of this project, there has been bast scientific achievements with one main focuse:  Early detection and intervention: Understanding the mechanisms of transformation and hidden resistance of incurable haematological malignancies. The overall goal of the [...]

Cima Universidad de Navarra (Spain) researchers lead an international study that has generated preclinical models that mimic the development and evolution of this blood cancer in patients. These models will allow the design of more effective and personalized therapies for multiple myeloma, the second most frequent hematological cancer. Nature Medicine publishes this study that opens a pathway for research [...]